Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone palmitate versus Risperdal Consta in schizophrenia
2004-002694-22Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2004
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Paliperidone palmitate with Risperdal Consta (2 arms). Started Dec 2004; status: completed.
02
Drugs
paliperidone palmitaterisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-002694-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002694-22.